Top Stories

Dialysis firm FMC sees robust 2024 earnings growth after strong Q4

Published by Uma Rajagopal

Posted on February 20, 2024

2 min read

· Last updated: January 31, 2026

Add as preferred source on Google
Fresenius Medical Care logo with financial growth indicators - Global Banking & Finance Review
The image showcases the Fresenius Medical Care logo alongside financial growth metrics, representing the company's strong Q4 performance and optimistic earnings forecast for 2024 in the dialysis sector.
Global Banking & Finance Awards 2026 — Call for Entries

Dialysis firm FMC sees robust 2024 earnings growth after strong Q4 GDANSK (Reuters) – Fresenius Medical Care on Tuesday forecast its core earnings to grow by a mid- to high-teens percentage this year, after the German dialysis specialist’s fourth-quarter earnings topped market expectations. Last year, the company’s adjusted operating income increased by 15% to 1.7 […]

Dialysis firm FMC sees robust 2024 earnings growth after strong Q4

GDANSK (Reuters) – Fresenius Medical Care on Tuesday forecast its core earnings to grow by a mid- to high-teens percentage this year, after the German dialysis specialist’s fourth-quarter earnings topped market expectations.

Last year, the company’s adjusted operating income increased by 15% to 1.7 billion euros ($1.83 billion).

“Based on the turnaround progress achieved last year, we have a strong foundation to build on to make 2024 a year of accelerated profitable growth,” CEO Helen Giza said.

Supported by its cost-cutting plan FME25, the German firm managed to save about 350 million euros during the year, almost 50 million euros more than initially planned.

In 2023, FMC sold 127 facilities with a headcount of more than 4,500 employees in the United States, Argentina and Australia.

FMC, which employs 120,000 people in 4,000 clinics globally, said its adjusted operating income grew 18% to 555 million euros in the October-December period, compared with a median consensus of 546 million in a poll by Vara Research.

Earnings for FMC, the world’s biggest dialysis provider, are recovering after they were hit by slower patient flows due to excess mortality rates during the pandemic.

Its turnaround plan and a 175-million-euro one-off payment related to a legal settlement in the United States also helped lift its quarterly numbers.

The company used the proceeds to reduce its net debt by 11% to 10.8 billion euros.

FMC proposed a dividend of 1.19 euros per share for 2023, representing a 6% annual increase.

Shares rose 1.3% in the Lang & Schwarz pre-market indications.

($1 = 0.9285 euros)

(Reporting by Andrey Sychev and Chiara Holzhaeuser in Gdansk; Editing by Milla Nissi and Sherry Jacob-Phillips)

Frequently Asked Questions

What is adjusted operating income?
Adjusted operating income refers to a company's earnings before interest and taxes, adjusted for non-recurring items, providing a clearer view of operational performance.
What is a dividend?
A dividend is a portion of a company's earnings distributed to shareholders, typically in cash or additional shares, reflecting the company's profitability.
What is net debt?
Net debt is a financial metric that subtracts a company's cash and cash equivalents from its total debt, indicating the actual debt burden.
What is a turnaround plan?
A turnaround plan is a strategic initiative aimed at improving a company's performance, often involving restructuring, cost reduction, and operational improvements.

Tags

Related Articles

More from Top Stories

Explore more articles in the Top Stories category